Nutra Pharma Corporation (OTCMKTS:NPHC) Stock Turns Volatile: What’s The Buzz?

August 1, 2021

Biotech company marketing Nyloxin, Pet Pain-Away, Equine Pain-Away as well as Luxury Feet, Nutra Pharma Corporation (OTCMKTS:NPHC) on July 26, 2021 announced filing a new provisional patent for protecting its IPR surrounding development of nerve agent counter measures. Rik J Deitsch, Chief Executive Officer of Nutra Pharma, said that the firm had announced project back in 2018. Deitsch added that the company findings demonstrate that the company’s products may protect…

Read More >>